IgG subclasses of human autoantibodies

Annales de Medecine Interne

Volumn 148, Issue 1, 1997, Pages 29-38

  Maran, Raya ^a,b   Dueymes, Maryvonne ^b   Le Corre, Rozenn ^b   Renaudineau, Yves ^b   Shoenfeld, Yehuda ^b   Youinou, Pierre ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

antibody; autoantibody; IgG subclass

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G;

AUTOIMMUNITY; HUMAN; IMMUNE SYSTEM; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELL MEMBRANE; HUMANS; IMMUNOGLOBULIN G; INFECTION;

EID: 0030903464     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. BURTON DR. Immunoglobulin G : functional sites. Mol Immnnol 1985 ; 22 : 161-206.
2. HAMILTON RG : Human IgG subclass measurements in the clinical laboratory. Clin Cliem 1987 ; 33 : 1707-25.
3. PUMPHREY R : Computer models of the human immunoglobulins : shape and seemental flexibility. Immunol Today 1986; 7:174-8.
4. SPIEGEBERG HL : Biological activities of immunoglobulins of different classes and subclasses. Ailv Immunol 1974 ; 19: 259-94.
5. YOUNT WJ, DORNER MM, KUNKEL HG, KABAT EA : Studies on human antibodies. IV. Selective variations in subgroup composition and genetic markers. J Exp Med 1980 ; 727: 633-46.
6. STEVENS R, DICHEK D, KELD B, HEINER D : IgGl is the predominant subclass of in vivo - and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. J Iminunol 1983 \3: 65-9.
7. SIBER OR, SCHUR PH : Correlation between serum IgG2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 1980 ; 303 : 178-82.
8. UMETSU DT, AMBROSINO DM, QUINTI I, SIHER GR, GEHA RS : Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG suclass deficiency. A , EnglJMed 1985 ; 313 : 247-51.
9. KAY RA, WOOD KJ, BERNSTEIN RM, HOLT PJL, HUMPHREY RSH : An IgG subclass imbalance in connective tissue disease. Ann Rheum Dis 1988 ; 47: 536-41.
10. JEFFERIS R, KU.MARARATNE DS : Selective IgG suclass deficiency : quantification and clinical relevance. Clin Exp Iminunol 1990 ; 81 : 357-67.
11. VAN DER GIESSEN M, Rossouw E, VAN VEEN TA et al : Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age. Clin Exp Iminunol 1975 ; 21 : 501-9.
12. HAMMARSTROM L, SMITH CI: IgG subclass changes in bacterial infections. Monogr Allergy 1986 ; 19 : 122-33.
13. MORELL A, SKVARIL F, HITZIG WH et al : IgG subclasses development of the serum concentration in «normal »infants and children. J Pediatr 1972 ; 50 : 960-4.
14. SNAPPER CM, MOND JJ : Towards a comprehensive view of immunoglobulin class switching. Iminunol Today 1993 ; 14 : 15-7.
15. DICKLER HB : Lymphocyte receptors for immunoglobulin. Adv Iminunol 1976 ; 24 : 167-214.
16. ANDERSON CL : Human IgG Fc receptors. Clin Immiinol Imimmopathol 1989 ; 53 : S63-S71.
17. GRIFFIN FM, GRIFFIN JA, LEIDER JE, SILVERSTEIN SC : Studies on the mechanism of phagocytosis I. Requirement for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane. J Exp Med 1975; 142: 1263-82.
18. MACLENNAN ICM, CONNELL GE, GOTCH FM : Effector activating determinants on IgG II. Differentiation of the combining sites for Clq from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbit IgG. Immunology 1974; 25: 303-10.
19. FRIDMAN WH, GABOURDIN-COMBE C, NEAUPORT-SAUTES C, GISLER RH : Characterization and function of T cell FCT receptor. Iminunol Rev 1981 ; 56 : 51-88.
20. SIMPSON SD, SNIDER DP, ZETTEL LA, KIYONO H, UNKELESS JC, ERNST PB : Soluble FcR block suppressor cell activity at low concentration HI vitro allowing isotype-specific antibody production. Clin Iminunol Imimmopathol 1996 ;167: 122-8.
21. LOONEY RJ, ABRAHAM GN, ANDERSON CL : Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J Immiinol 1986 ; 136 : 1641-7.
22. GUYRE PM, MORGANELLI PM, MILLER R : Recombinant immune Interferon increases immunoglobulin G receptors on cultured human mononuclear phasocytes. J Clin Invest 1983 ; 72 : 393-7.
23. ANDERSON CL, SHEN L : Phagocytic capacity of individual human Fc receptor classes. FASEB J 1989 ; 3 : Al 104-14.
24. ANDERSON CL, GUYRE PM, WHITIM JC, RYAN DH, LooNEY RJ, FäNGER MW : Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes: antibody characterization and induction of superoxyde production in a monocyte cell line. J Biol Cliem 1986 ; 267 : 12856-64.
25. FANGER MW, SHEN L, GRAZIANO RF, GUYRE PM : Cytotoxicity mediated by human Fc receptors for IgG. Iminunol Today 1989; 10:92-9.
26. ANDERSON CL, LOONEY RJ, CULP DJ et al : Human alveolar and peritoneal macrophages bear three distinct classes of Fc receptors for IgG. J Immunol 1990 ; 145 : 196-201.
27. LOONEY RJ, RYAN DH, TAKAHASHI K et al : Identification of a second class of IgG Fc receptors on human neutrophils : a 40 kD molecule also found on eosinophils. J Exp Med 1986 ; 163 : 826-36.
28. ROSENFELD SI, ANDERSON CL : Fc receptors of human platelets. In : KUNICKI TJ, GEORGE JN, eds. Platelet Immunology. 1986, 337-53.
29. PERUSSIA B, STARR S, ABRAHAM S, FANNING V, TRINCHIERI G : Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor function. I. Characteriation of the lymphocyte subset reactive with B73.1. J 1/nmwwl 1983 ; 130 : 2133-41.
30. HUIZINGA TWJ, DE HASS M, KLEIJER M et al : Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest 1990 ; 86 : 416-23.
31. KHAYAT D, LE GOFF P, SOUBRANE C, MAGADUR G, YouiNOU P : Fc-gamma receptor III shedding by polymorphonuclear cells in rheumatoid arthritis. Med Sei Res 1990 ; 18: 893-4.
32. LAMOUR A, SOUBRANE C, ICHEN M, FENNEC YL, KHAYAT D, YOUINOU P : Fc-gamma receptor III shedding by polymorphonuclear cells in primary Sjögren syndrome. Eur J Clin Invest 1993 ; 23 : 97-101.
33. HUTIN P, LAMOUR A, PENNEC YL et al : Cell-free Fcyreceptor III in sera from patients with systemic lupus erythematosus : correlation with clinical and biological features. Int Arch Allergy Immunol 1994 ; 103 : 23-7.
34. LAMOUR A, LE CORRE R, PENNEC YL, CARTRON J, YOUINOU P : Heterogeneity of neutrophil antibodies in patients with primary Sjögren's syndrome. Blood 1995 ; 86: 3553-9.
35. THEZE JI, LOWY M, SEMEN C et al : Control of isotype expression by helper clones and suppressor cells. Ann Immunol\983;I34D: 55-61.
36. CALLARD RE, TURNER MW : Cytokines and Ig Switching : evolutionary divergence between mice and humans. Immunol Today 1990 ; II : 200-3.
37. WINTER E, KRAWINKEL U, RADBRUCH A : Directed Ig class switch recombination in activated murine B cells. EMBO J 1987 ;6: 1663-71.
38. OCHEL M, VOHR HW, PFEIFFER C, GLEICHMANN E : IL4 is required for the IgE and IgGl increase and IgGl autoantibody formation i mice treated with mercuric chloride. J Immunol 1991 ; 146 : 3006-11.
39. PURKERSON JM, ISAKSON PC : Interleukin 5 (IL5) provides a signal that is required in addition to IL4 for isotype switchinc to immunoglobulin (Ig) G and IgE. J Exp Med 1992; 775: 973-82.
40. SNAPPER CM, PESCHEL C, PAUL WE : IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J Immunol 1988 ; 140 : 2121-7.
41. DUEYMES M, BARRIER J, BESANCENOT JF et al : Interleukin 4-reIated isotypic distribution of anti-double-stranded DNA antibodies in systemic lupus erythematosus. IntArch Allergy Immunol 1993 ; 707 : 408-15.
42. WHITTINGHAM S, MATHEWS JD, SCHANFIELD MS et al : Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen. Clin Exp Immunol 1980 ; 40 : 8-15.
43. KAGNOFF MF : Two genetic loci control the murine immune response to A-gliadin, a wheat protein that activates coeliac sprue. Nature 1982 ; 296 : 158-60.
44. MORROW PR, RENNICK DM, BENJAMINI E : The antibodody response to a single antigenic determinant of the tobacco mosaic virus protein (TMVP) : effects of allotype-linked genes and restricted heterogeneity of the response. J Immunol 1983 ; 737:2875-81.
45. MORRELL A, SKVARIL F, STEINBERG AG et al : Correlation between the concentrations of the four subclasses of IgG and Gm allotypes in normal human sera. J Immunol 1972 ; 108: 195-206.
46. SARVAS H, RAUNTON N, MAKELA O : Allotype-associated differences in concentrations of human IgG subclasses. J Clin Immunol 1991 ; 77 : 39-45.
47. HASSAN MS, ISLAM KB, HAMMARSTRO.M Let al : Regulation of Cy3 expression. Role of switch in the allotype-associated variation of human serum IgG3 levels. J Immunol 1992 ; 148 : 2555-62.
48. PRESSLER T, PANDEY JP, ESPERSEN F et al : Immunoglobulin allotypes and IgG subclass antibody response to Pseudomononas aeruginosa antigens in chronically infected cystic fibrosis patients. Clin Exp Immunol 1992 ; 90 : 209-14.
49. MARTINI A, PLEBANI A, RAVELLI A et al : IgG subclass serum levels in juvenile chronic arthritis. Ann Rheum Dis 1986 ; 45 : 400-4.
50. MARTINI A, AVANZINI MA, RAVELLI A, DE BENEDETTI F, BURGIO RG : Variation of serum IgG subclass concentrations with disease activity in juvenile chronic arthritis. Ann Rheum Dis 1989 ; 48 : 582-5.
51. JAYNE DRW, WEETMAN AP, LOCKWOOD CM : IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991 ; 84: 476-81.
52. SURH CD, COOPER AE, COPPEL RL et al : The predominance of IgG3 and IgM isotype anti-mitochondrial antibodies against recombinant fused mitochondrial peptide in patients with primary biliary cirrhosis. Hepatology 1988 ; 8: 290-5.
53. RUBIN RL, TANG FL, LUCAS AH, SPIEGELBERG HL, TAN EM : IgG subclasses of anti-tetanus toxoid antibodies in adult and newborn normal subjects and in patients with systemic lupus erythematosus, Sjögren's syndrome and drug-induced autoimmunity. J Immunol 1986 ; 137: 2322-7.
54. LJUNGGREN K, BROLIDEN PA, MANSSON LM, JONDAL M, WAHREN B : IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages, din Exp Immunol 1988 ; 73 : 343-7.
55. BROLIDEN PA, MANSSON LM, ROSEN J, JONDAL M, WAHREN B : Fine specificity of IgG subclass response to group antigens in HIV-1 infected patients. Clin Exp Immunol 1989; 76: 216-21.
56. MATHIESEN T, PERSSON MAA, SUNDQVIST VA, WAHREN B : Neutralization capacity and antibody dependent cell-mediated cytotoxicity of separated IgG subclasses 1, 3 and 4 acainst herpes simplex virus. Clin Exp Immunol 1988 ; 72:211-5.
57. GiLLJAN G, WAHREN B : Properties of IgG subclasses to human cytomegalovirus. J Virol Methods 1989 ; 25 : 139-51.
58. DHANDAYUTHAPANI S, IZUMI S, ANANDAN D, BHATIA VN : Specificity of IgG subclass antibodies in different clinical manifestations of leprosy. Clin Exp Immunol 1992 ; 88 : 253-57.
59. HUSSAIN R, GROGL M, OTTESEN EA : IgG antibody suclasses in human filariasis. Differential subclass recognition of parasitic antigens correlates with different clinical manifestations of infection. J Immunol 1987 ; 139 : 2794-98.
60. LJUNGSTROM I, HAMMARSTROM L, KOCIECKA W, SMITH CIE : The sequential appearance of IgG subclasses and IgE during the course of Trichinella spiralis infection. Clin Exp Immunol 1988 ; 74 : 230-5.
61. EVENGARD B, HAMMARSTROM L, SMITH CIE, LINDER E : Early antibody responses in human schistosomiasis. Clin Exp Immunol 1990 ; 80 : 69-76.
62. BOCTOR FN, PETER JB : IgG subclasses in human chronic schistosomiasis : over-production of schistosome-specific and non-specific IgG4. Clin Exp Immunol 1990 ; 82 : 574-8.
63. DAFA'ALLA TH, GHALIB HVV, ABDELMAGEED A, WILLIAMS JF : The profile of IgG and IgG subclasses of onchocerciasis patients. Clin Exp Immunol 1992 : 88 : 258-63.
64. PRESSLER T, MANSA B, JENSEN T et al: Increased IgG2 and IgG3 concentration is associated with advanced Pseudoinonas aeruginosa infection and poor pulmonary function in cystic fibrosis. Ada Paediat Scand 1988 ; 77 : 576-82.
65. PRESSLER T, PEDERSEN SS, ESPERSEN Fetal: IgG subclass antibodies to Pseudomonosa aeruginosa in sera from patients with chronic P. aeruginosa infection investigated by ELISA. Clin Exp Immunol 1990 ; 81 : 428-34.
66. PRESSLER T, PEDERSEN SS, ESPERSEN Fetal: IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P aeruginosa infection. Paediat Pulm. 1992 ; 14 : 44-51.
67. PREUD'HOMME JL : Que va-t-il se passer demain àpropos des sous-classes d'IgG (leur dosage, leur déficit, leur signification) ? Ann Med Interne 1992 ; 143 : 319-21.
68. OXELIUS VA, LAURELL AB, LINDQWUIST B et al : IgG subclasses in selective IgA deficiency : importance of IgG2-IgA deficiency. N Engl J Med 1981 ; 304 : 1476-7.
69. HAY EM, FREEMONT AJ, KAY RA et al : Sélective polyclonal increase of immunoglobulin Gl subclass: a link with Sjögren's syndrome. Ann Rheum Dis 1990 ; 49 : 373-7.
70. ZHANG L, WEETMAN AP, JAYNE DRW et al : Anti-mitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis. Clin Exp Immunol 1992 ; 88 : 56-61.
71. MARAN R, DUEYMES M, ADLER Y, SHOENFELD Y, YOUINOU P : Isotypic distribution of anti-pyruvate deshydrogenase antibodies in patients with primary biliary cirrhosis and their family members. J Clin Immunol 1994 ; 14 : 323-6.
72. MUNTHE E, NATVIG JB : Immunoglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells. Clin Exp Immunol 1972 ; 12 : 55-70.
73. HUFFMAN WL, GOLDBERG MS, SMILEY JD : Immunoglobulin G3 subclass production by rheumatoid synovial tissue. J Clin Invest 1982 ; 69 : 136-44.
74. EGELAND O, LEA T, SAARI G, MELLBYE OJ, NATVIG JB : Quantification of cells secreting rheumatoid factor IgG, IgA and IgM classes after elution from rheumatoid synovial tissue. Arthritis Rheum 1982 ; 25 : 1445-50.
75. SHAKIB F, STANWORTH DR : IgG subclasses composition of rheumatoid arthritis sera and joint fluid. Ann Rheum Dis 1976 ; 35 : 263-6.
76. HABER PL, KUBAGAWA H, KOOPMAN WJ : Immunoglobulin subclass distribution of synovial plasma cells in rheumatoid arthritis determined by use of monoclonal antisubclass antibodies. Clin Fmiminol Immwwpathol 1985 ; 35:346-51.
77. JOHNSTONE R, GRIFFITHS LD, CALVERT JE : Analysis of the IgG subclass production from rheumatoid arthritis synovial cell s cultures. Autoimmunity 1991 ; 10 : 35-9.
78. VINCENT C, SERRE G, BASILE JP et al : Subclass distribution of IgG antibodies to the rat oesophagus stratum corneum (so-called anti-keratin antibodies) in rheumatoid arthritis. Clin Exp Immuiwl 1990 ; 57 : 83-9.
79. TOKANO Y, YASUMA M, HARADA S et al : Clinical significances of IgG subclasses of anti-Sm and Ul ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease. J Clin I minimal 1991 ; 77 : 317-25.
80. WINKLER TH, HENSCHEL TA, KALIES letal: Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus. Clin Exp Imimmol 1988 ; 72 : 434-9.
81. GHARAVI AE, HARRIS EN, LOCKSHIN MD, HUGHES GRV, ELKON KB : IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus. Ann Rheum Dis 1988 ; 47 : 286-90.
82. Loisou S, CORNER C, WEETMAN AP, WALPORT MJ : Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol 1992 ; 90 : 434-9.
83. RUBIN RL, TANG FL, CHAN EKL et al : IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjögren's syndrome, and drug-induced autoimmunity. J Immunol 1986; 737:2528-34.
84. TOKANO Y, YASUMA M, HARADA S et al : Anti-Sm and Ul ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease. J Clin Immunol 1991 ; 77 : 317-27.
85. BROUWER E, COHEN TERVAERT JW, HORST G étal: Predominance of IgG 1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991 ; 83 : 379-86.
86. SEGELMARK M, WIESLANDER J : IgG subclass of antineutrophil cytoplasm autoantibodies. Nephrol Dial Transplant 1993 ; 8 : 696-702
87. MULDER AH, STEGEMAN CA, KALLENBERG CG : Activation of granulocytes by anti-neutrophil cytoplasmic antibodies ANCA in Wegener's granulomatosis : a predominant role for the IgG3 subclass of ANCA. Clin Exp Immunol 1995 ; 707 : 227-32.
88. CAMBRIDGE G, WILLIAMS M, LEAKER B, CORBETT M, SMITH CR : Anti-myelopreoxidase antibodies in patients with rheumatoid arthritis : prevalence, clinical correlates and IgG subclass. Ann Rheum Dis 1994 ; 53 : 24-9.
89. MARAN R, DUEYMES M, FENNEC Y étal: Predominance of IgGl subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome. J Aittoimmitn 1993 ; 6: 379-87.
90. DEVEY ME, LEE SR, LE PAGE S, FELDMAN R, ISENBERG DA : Serial studies of the IgG subclass and functional affinity of DNA antibodies in systemic lupus erythematosus. J Autoimmunity 1988 ; 7 : 483-94.
91. BARRA A, AUCOUTURIER P, PREUD'HOMME JL : Isotypic distribution of human anti-tyroglobulin IgG antibodies : methodological difficulties. Diagnostic Iminiinol 1986 ; 4 : 228-32.
92. HAAS GG, D'CRUZ OJ : The predominance of IgGl and IgG3 subclass antisperm antibodies in infertile patients with serum antisperm antibodies. Am J Reprodiict linimtnol 1991 ; 26 : 104-9.
93. BOWMAN C, AMBRUS K, LOCKWOOD CM : Restriction of human IgG subclass expression in the population of autoantibodies to glomerular basement membrane. Clin Exp 7m mmo/1987;69:341-9.
94. MILLWARD A, HUSSAIN MJ, PEAKMAN M et al : Characterization of islet cell antibody in insulin dependent diabetes : evidence for IgGl subclass restriction and polyclonality. Clin Exp Immunol 1988 ; 71 : 353-6.
95. OMAR MA, SRIKANTA S, EISENBARTH GS : Human islet cell antibodies : immunoglobulin class and subclass distribution defined by monoclonal antibodies. Diabetes Res 1987 ;4: 155-7.
96. Dozio N, BELLONI C, GIRARDI AM et al : Heterogeneous IgG subclass distribution of islet cell antibodies. JAutoimmim 1994; 7: 45-53.
97. HOWER LW, GAWRYL MS, DE LA FUENTE B : Immunochemical characterization of factor VIII inhibitors. Prog Clin Biol Research 1984 ; 750 : 73-85.
98. SHIRAKATA Y, SHIRAISHI S, SAYAMA K, MIKI Y : Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol 1990 ; 17 : 661-6.
99. ROCK B, MARTINS CR, THEOFILOPOULOS AN et al : The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus. N Engl J Med 1989 ; 520 : 1463-9.
100. PAREKH RB, DWEK RA, SUTTON BJ et al : Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 5/6:452-7.
101. AXFORD JS, MACKENZIE L, LYDYARD PM et al : Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet 1987 ;//: 1486-88.
102. PAREKH R, ROITT I, ISENBERG D, DWEK R, RADEMACHET T : Ager-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 1988 ; 167 : 1731-6.
103. TOMANA M, SCHROHENLOHER RE, KOOPMAN WJ, ALARCON GS, PAUL WA : Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 1988; 31 : 333-8.
104. NEWKIRK MM, LEMMO A, RAUCH J : Importance of the IgG isotype, not the state of glycosylation, in determining human rheumatoid factor binding. Arthritis Rheum 1990 ; 33 : 800-9.
105. TSUCHIYA N, ENDO T, MATSUTA K et al : Effects of galactose depletion from oligosaccharide chains on immunological activitis of human IgG. J Rhiimalol 1989 ; 76 : 285-90.
106. BHOL K, NATARAJAN K, NAGARWALLA N, MOHIMEN A, AOKI V, RAZZAQUE AHMED A : Correlation of peptide specificity and IgG subclass with .pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris : a model for autoimmunity. Proc Natl Acacl Sei USA 1995 ; 92 : 5239-43.
107. BHOL K, MOHIMEN A, RAZZAQUE AHMED A : Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatology 1994 ; 189 (suppl 1) : 85-9.
108. JENSEN PJ, BAVID J, MORIOKA S, LESSIN S, LAZARUS GS : Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 1988 ; 90 : 777-82.
109. VAN DER ZEE JS, VAN SWIETEN P, AALBERSE RC : Serologie aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J Immimol 1986 ; 137 : 3566-71.
110. SAKANE T, STEINBERG AD, REEVES JP, GREEN I : Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets. J Clin Invest 1979 ; 64 : 1260-9.
111. HONDA M, SAKANE T, STEINBERG AD et al : Studies on immune functions of patients with systemic lupus erythematosus. Antibodies to desialized rather than intact T cells preferentially bind to and eliminate suppressor effector T cells. J Clin Invest 1982 ; 69 : 940-9.
112. JEFFERIS R, REIMER CB, SKVARIL F et al : Evaluation of monoclonal antibodies having specificity for human IgG subclass : results of an IUISAVHO collaborative study. Immunol Lett 1985 ; 10 : 223-52.
113. RONDA N, HAURY M, NOBREGA A, KAVERI SV, COUTINHO A, KAZATCHKINE MD : Analysis of natural and disease-associated autoantibody repertoires : anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Im Immunol 1994 ; 6 : 1651-60.